Bo Tan

1.5k total citations
60 papers, 1.1k citations indexed

About

Bo Tan is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Bo Tan has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Pharmacology and 14 papers in Biochemistry. Recurrent topics in Bo Tan's work include Sulfur Compounds in Biology (12 papers), Pharmacological Effects of Natural Compounds (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Bo Tan is often cited by papers focused on Sulfur Compounds in Biology (12 papers), Pharmacological Effects of Natural Compounds (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Bo Tan collaborates with scholars based in China, Macao and United Kingdom. Bo Tan's co-authors include Yi Zhun Zhu, Xiaoqian Li, Shan Cong, Zhonghua Wu, Qingxun Hu, Dan Wu, Yi‐Chun Zhu, Yicheng Mao, Sheng Jin and Furong Qiu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Bo Tan

59 papers receiving 1.1k citations

Peers

Countries citing papers authored by Bo Tan

Since Specialization

Citations

This map shows the geographic impact of Bo Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Tan more than expected).

Fields of papers citing papers by Bo Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Tan. The network helps show where Bo Tan may publish in the future.

Co-authorship network of co-authors of Bo Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Tan. A scholar is included among the top collaborators of Bo Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Tan. Bo Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevating cytosolic NADPH metabolism in endothelial cells ameliorates vascular aging 2025 ·Nature Communications ·Dan Wu, Bo Tan, (unknown), Haoqi Li, Huimin Li, (unknown), (unknown), (unknown), Xin Dong, Wang Wang, Qingxun Hu	1
2	Asynchronous changes of hydrogen sulfide and its generating enzymes in most tissues with the aging process 2024 ·Bioscience Reports ·(unknown), Bo Tan, Lu Ao, (unknown), (unknown), Yuxin Miao, (unknown), Qian Chen, Xu Teng, (unknown), Yuming Wu	1
3	Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9 2024 ·Cardiovascular Drugs and Therapy ·(unknown), Huaxing Zhang, Bo Tan, (unknown), (unknown), Lixia Zhang, Danyang Tian, Lin Xiao, Hongmei Xue, Qi Guo, Xu Teng, Sheng Jin, Cuixia An, Yuming Wu	3
4	Mechanism of Qingdai in Alleviating Acute Lung Injury by Inhibiting the JAK2/STAT3 Signaling Pathway 2024 ·Journal of Inflammation Research ·Lu Qi, Shun Wang, Tao Guo, (unknown), (unknown), (unknown), (unknown), Bo Tan, (unknown)	0
5	SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4 2023 ·Journal of Translational Medicine ·Yanzhe Wang, Ming Wu, (unknown), Bo Tan, (unknown), Di Huang, Chaoyang Ye	3
6	Gβγ subunit inhibitor decreases DOM-induced head twitch response via the PLCβ/IP3/Ca2+/ERK and cAMP signaling pathways 2023 ·European Journal of Pharmacology ·Huili Zhu, Xiaoqian Liu, Xiaoxuan Wang, Yulei Li, Fang Ma, Bo Tan, (unknown), Fenghua Fu, Ruibin Su	5
7	Network Pharmacology and Experimental Validation of the Anti-Inflammatory Effect of Tingli Dazao Xiefei Decoction in Acute Lung Injury Treatment 2023 ·Journal of Inflammation Research ·(unknown), Xiaoqian Li, Dan Gao, (unknown), Shun Wang, Bo Tan, (unknown)	1
8	Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl 2022 ·Frontiers in Pharmacology ·(unknown), Junjie Zhang, Shaowen Wang, Huan Gao, Yi Sun, Xiaoqian Liu, Wei Fu, Bo Tan, Ruibin Su	4
9	Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine 2022 ·Frontiers in Medicine ·Yanzhe Wang, Ming Wu, Feng Yang, Junyan Lin, Li Zhang, (unknown), Dong‐Ping Chen, Bo Tan, Di Huang, Chaoyang Ye	4
10	Cystathionine γ lyase S-sulfhydrates Drp1 to ameliorate heart dysfunction 2022 ·Redox Biology ·Dan Wu, Bo Tan, Yuanyuan Sun, Qingxun Hu	26
11	Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR/HIF-1α/VEGF signaling pathway 2020 ·Inflammation Research ·Xiaoqian Li, Shan Cong, Zhonghua Wu, (unknown), (unknown), Bo Tan	83
12	Emodin Inhibits Lipopolysaccharide-Induced Inflammation by Activating Autophagy in RAW 264.7 Cells 2020 ·Chinese Journal of Integrative Medicine ·(unknown), Bo Tan, Lei Jiang, Zhonghua Wu, (unknown), Xiaoqian Li, (unknown)	8
13	<p>A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway</p> 2019 ·International Journal of Nanomedicine ·(unknown), Ying Yu, Lingling Chang, Bo Tan, Wanwan Jia, Ying Xiong, Tao Dai, Rui Zhong, (unknown), Van Minh Le, Peter Rose, Zhijun Wang, Yicheng Mao, Yi Zhun Zhu	32
14	Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro 2018 ·Acta Pharmacologica Sinica ·(unknown), Yujuan Fan, Bo Tan, (unknown), Yue Li, Linlin Zhang, Jian Jiang, Furong Qiu	16
15	Metabolic characteristics of Tanshinone I in human liver microsomes and S9 subcellular fractions 2018 ·Xenobiotica ·Yue Li, Yujuan Fan, (unknown), (unknown), Guo‐Fu Li, Yiyang Hu, Jian Jiang, Bo Tan, Furong Qiu	9
16	Amelioration of mitochondrial dysfunction in heart failure through S-sulfhydration of Ca2+/calmodulin-dependent protein kinase II 2018 ·Redox Biology ·Dan Wu, Qingxun Hu, Bo Tan, Peter Rose, Deqiu Zhu, Yi Zhun Zhu	40
17	Simultaneous determination of glipizide and its four hydroxylated metabolites in human urine using LC–MS/MS and its application in urinary phenotype study 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·Bo Tan, (unknown), Wei-An Yuan, Yue Li, Lei Jiang, Jian Jiang, Furong Qiu	9
18	AMPK Serves as a Therapeutic Target Against Anemia of Inflammation 2016 ·Antioxidants and Redox Signaling ·(unknown), Hong Xin, Wenbo Tang, Yiming Li, Zhaoyun Zhang, (unknown), Lei Miao, Bo Tan, Xiling Wang, Yi Zhun Zhu	24
19	Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats 2012 ·Acta Pharmacologica Sinica ·Yuanting Zheng, Jianhua Zhu, Guo Ma, Qing Zhu, Ping Yang, Bo Tan, Jinlian Zhang, (unknown), Jialin Xu, Yi Zhun Zhu, Weimin Cai	13
20	The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects 2009 ·European Journal of Clinical Pharmacology ·Bo Tan, (unknown), Xiaoyan Chen, Xiaohua Zhao, Guoxin Li, Dafang Zhong	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact